Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 to Prevent Severe Asthma Exacerbations
NCT02687815Phase 2Terminated
- Sponsor
- Juan C. Celedón
- Start
- Feb 2016
- Primary completion
- Sep 2019
- Modality
- Transdermal Patches, Orthosteric Ligands, Hydrogel Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cholecalciferol cream in asthma (2 arms), sponsored by Juan C. Celedón. Primary endpoint: Days to a Severe Asthma Exacerbation at 48 weeks. Started Feb 2016; status: terminated.
02
Drugs
cholecalciferol cream
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02687815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02687815.